Filing Flows › Gentex (GNTX) › R&D spending
Gentex (GNTX) R&D spending by quarter
Gentex's R&D spending was $51.6M in Q3 2026 (third quarter 2026), +5% from Q2 2026. Over the last 7 quarters it ranged from $45.9M (Q1 2025) to $53.2M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $51.6M | +5% | -2% |
| Q2 2026 | $49.3M | -5% | -4% |
| Q1 2026 | $51.7M | -3% | +12% |
| Q4 2025 | $53.2M | +1% | — |
| Q3 2025 | $52.6M | +2% | — |
| Q2 2025 | $51.5M | +12% | — |
| Q1 2025 | $45.9M | — | — |
Q3 2026 at a glance
Gentex, Q3 2026: revenue $648M (-1% year over year), operating margin 17.8%, net earnings $90.6M, operating cash flow $84.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Gentex's R&D spending?
Gentex's R&D spending was $51.6M in Q3 2026 (third quarter 2026), +5% from Q2 2026.
How has Gentex's R&D spending changed?
Over the last 7 quarters it ranged from $45.9M (Q1 2025) to $53.2M (Q4 2025).